Stem Cell Agency Awards $39 Million [California]
By Los Angeles Times,
Los Angeles Times
| 09. 10. 2005
California's stem cell research agency awarded the first of a planned $3 billion in grants Friday, announcing that a little less than $39 million would go to UCLA, UC Irvine, Stanford and several other campuses to help set up programs to train scientists.
Although the amount was relatively small, competition among 26 universities and nonprofit institutions was stiff because those selected hope to be at the front of the line for more lucrative public financing to come.
The agency's Independent Citizens' Oversight Committee chose 16 winners.
The agency, the California Institute for Regenerative Medicine, was set up by Proposition 71, which voters passed last year to fund a program of research using embryonic stem cells to develop potential treatments for disease.
For now, the institute doesn't have any of its own money to give out. Lawsuits filed by anti-tax and antiabortion groups have blocked the state from issuing the bonds that Proposition 71 authorized.
As a result, the agency's chairman, Robert Klein, has been asking private philanthropic groups to fill the void with the expectation that they will be repaid...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...